Effector Therapeutics Inc (EFTR) — Tangible Net Worth Ratio
Effector Therapeutics Inc (EFTR) has a Tangible Net Worth Ratio of 100.0% as of March 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($827.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Effector Therapeutics Inc book value and equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Effector Therapeutics Inc Tangible Net Worth Ratio (2021–2022)
This chart shows how Effector Therapeutics Inc's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2022. As of March 2024, the ratio stands at 100.0%, reflecting net assets of $827.00K with intangible assets of $0.00 USD. Also explore EFTR net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Effector Therapeutics Inc (2021–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Effector Therapeutics Inc from 2021 to 2022, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Effector Therapeutics Inc.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $3.90 Million | $0.00 | $29.08 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $17.28 Million | $0.00 | $54.06 Million | — |